-+ 0.00%
-+ 0.00%
-+ 0.00%

Press Release: Relmada Therapeutics Appoints CNS Drug Development Veteran Michael Quirk as Senior Advisor for Sepranolone Program

Dow Jones·06/11/2026 11:00:00

Please log in to view news